Share this page

Webcast Wednesday

Session 52: Future infertility management

R.W. Rebar (U.S.A.)
When will infertility be explained?  
P.M.M. Bossuyt (The Netherlands)
The future of randomized clinical trials  

 

Session 53: Are human embryonic stem cells ready for regenerative medicine?

R. Vassena (Spain)
hESC and iPSC as models for human development and disease  
B. Reubinoff (Israel)
Cell therapy with pluripotent stem cells (hESC and iPS)  

 

Session 54: New findings in reproductive oncology

E. Somigliana (Italy)
Ovarian cancer and the incessant menstruation hypothesis  

 

Session 55: ASRM/Society of Reproductive Biologists and Technologists Exchange Symposium: Optimizing the culture and selection of human embryo in 2013

C. Racowsky (U.S.A.)
Current status of non-invasive approaches for embryo assessment and selection  
M.J. Tucker (U.S.A.)
Evaluating media systems and day of transfer for human embryos: What are optimal?  

 

Session 56: From experimental to established: ESHRE guidelines and position papers

G.A.J. Dunselman (The Netherlands)
The 2013 ESHRE guideline on the management of women with endometriosis.  

 

Session 57: Time lapse: the real revolution for embryo assessment?

L. Best (United Kingdom)
Does one model fit all? Testing a published embryo selection algorithm on independent time-lapse data  
C. Pirkevi (Turkey)
Blastocyst culture using time-lapse in good prognosis IVF patients and elective SET: a randomized pilot study  

 

Session 58: Basics of reproductive endocrinology

Q. Zhang (China)
miR-181a promotes mouse granulosa cell apoptosis by suppressing sirt1-mediated foxo1 deacetylation  
C. Tang (China)
Hedgehog signaling regulates steroid hormone production in human placentas  
Q. Zhang (China)
MicroRNA 132 promotes estradiol release from mouse granulosa cells by translational repression of Nr4a2  
R. Alhamdan (United Kingdom)
Elucidating the role of natriuretic peptides (NPs) in the regulation of the key angiogenic mediator, vascular endothelial growth factor (VEGF)  
A. Elfituri (United Kingdom)
Anti-mullerian hormone (AMH) has a direct regulatory role on theca cell function  

 

Session 59: Endometrium

M. Cao (Hong Kong)
Characterization of mouse endometrial labeling retaining cells after uterine remodeling  
Y. Yamagata (Japan)
Genome-wide DNA methylation profiling in cultured eutopic and ectopic endometrial stromal cells  
X. Jin (China)
Nur77 cooperates with FOXO1A to regulate decidual prolactin expression in human endometrial stromal cells  
A. Tapia Pizarro (Chile)
Signal transduction pathways activated by human chorionic gonadotropin (hCG) in human endometrial stromal cells (ESC)  
Y. Jiang (China)
Mirna-21 is a novel regulator of NUR77 and KLF12 mediated decidual prolactin expression in human endometrial stromal cells  

 

Session 60: Perinatal outcome after ART

C. Stora (France)
Issue of assisted reproductive techniques in HIV-infected women: a case-control retrospective study  
A. Hagman (Sweden)
Obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome - a Nordic cohort study  
T. Mukaida (Japan)
Perinatal outcome of children born after vitrification of blastocysts (6467 cycles with 2059 babies in 12 years experiences)  
B. Carrasco Canal (Spain)
Does embryo culture medium influence birthweight of the newborn - a randomised control trial.  

 

Session 61: Effects of interventions on embryo quality

R. Naik (United Kingdom)
Impact of Hepatitis B and Hepatitis C infections on embryo quality during In-vitro fertilization  
B. Shapiro (U.S.A.)
Factors affecting success of blastocyst transfer into an artificially prepared uterine environment differ from those affecting outcome of fresh autologous blastocyst transfer  
S. Catt (Australia)
A randomized trial investigating the effectiveness and safety of three IVF laboratory disinfectants  
C. Kailasam (United Kingdom)
Prospective study of the effect of early coasting on blastocyst development and outcome of fertility treatment in an IVF/ICSI program  
L. Herrero Grassa (Spain)
Oocyte versus embryo vitrification: searching the most efficient approach when preventing OHSS after agonist triggering  

 

Session 62: Quality management and regulation in the ART lab

K. Tilleman (Belgium)
From quality control to total quality management in the IVF lab  
B.C. Tarlatzis (Greece)
The European Tissue Directive: a curse or a blessing?  

 

Session 63: New ART interventions may, under certain circumstances, be introduced without a clinical trial? (Debate)

S. Fishel (United Kingdom)
For  

 

Session 64: Endometriosis-associated pain

I.S. Fraser (Australia)
Endometrium, nerves and endometriosis  
K. Berkley (U.S.A.)
Central nervous system (CNS) mechanisms of pain in endometriosis  

 

Session 65: Paramedical invited session – Nursing (Debate): Patients have the right for an anonymous donor

L. Schmidt (Denmark)
Pro  
C. Gottlieb (Sweden)
Con  
 

Session 66: Embryo quality: does it predict pregnancy?

C. Theofanakis (Greece)
Research of circadian genes (Clock Bmal1, Per1, Per2, Cry1, Cry2) control over early embryo development, ovaries and liver in vitro  
S. Ohgi (Japan)
Use of trophectoderm quality versus use of inner cell mass quality to predict pregnancy after a single blastocyst transfer in women of advanced maternal age  

 

Session 67: Scientific challenges in early pregnancy achievement

D. Schust (U.S.A.)
Could a novel, retrovirally-derived inhibitor of trophoblast syncytialization play a role in limiting cell fusion between extravillous trophoblast and maternal decidua  

 

Session 68: The impact of genetics in andrology

H. Asakura (Japan)
Clinical significance of sperm DNA damage on embryo implantation efficiency and spontaneous pregnancy loss after assisted reproductive therapy  
A. Salas-Huetos (Spain)
MicroRNA expression profile in spermatozoa from fertile donors  
T. Freour (France)
Comparative proteomic analysis coupled with conventional protein assay as a strategy to identify predictors of successful testicular sperm extraction in patients with non-obstructive azoospermia (NOA)  
A. Ferlin (Italy)
Molecular karyotyping of human single sperm by array- comparative genomic hybridization  

 

Session 69: Clinical endocrinology

M. Grynberg (France)
First birth achieved after in-vitro maturation of oocytes from a woman with resistant ovary syndrome  
C. Verhaak (The Netherlands)
Long-term effects of oxandrolone treatment in childhood on neurocognition, wellbeing and social-emotional functioning in young adults with Turner syndrome  
A. Busnelli (Italy)
IVF outcome in treated hypothyroidism  
M. Montag (Germany)
Differences in morphokinetic parameters between in-vitro maturation (IVM) and COS-ICSI analysed by time-lapse imaging  

 

Session 70: Challenges in cryopreservation

N. Potdar (United Kingdom)
Oocyte cryopreservation in the 21st century and post warming fertility outcomes: a systematic review and meta-analysis  
A. Mikich (Brazil)
Metal cryovial: a new, promising system for clinical grade vitrification of ovarian tissue  
N. Desai (U.S.A.)
The new Rapid i carrier is effective for human embryo vitrification at both the cleavage and blastocyst stage: preliminary clinical pregnancy and live birth outcomes  
T. Trapphoff (Germany)
Maturation in presence of a glutathione donor protects spindle integrity and chromosomal alignment in vitrified mouse metaphase II oocytes  

 

Session 71: Surgery

O. Rustamov (United Kingdom)
Reproductive surgery and ovarian reserve  
P. Tokdemir Calis (Turkey)
Adnexal torsion in a rat model: does ischemia-reperfusion injury affect follicule cohort?  
I. Kozachenko (Russia C.I.S.)
Reproductive outcomes after hysteroscopic resection of the uterine septum